Re-stimulated tumor-infiltrating lymphocytes (TILs) clinical trials

"Re-Stimulated" TILs and IL-2 Therapy for Platinum Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

This study is for women with advanced ovarian, fallopian tube, or peritoneal cancer that has come back and isn’t responding to standard chemotherapy. It’s testing a new approach using special immune cells from your own body, called TILs, along with other treatments to see if they can fight the cancer.